The global market for Kidney Cancer Targeted Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Kidney Cancer Targeted Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kidney Cancer Targeted Therapy.

The Kidney Cancer Targeted Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Kidney Cancer Targeted Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Kidney Cancer Targeted Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Kidney Cancer Targeted Therapy Market Report

Report Metric	Details
Report Name	Kidney Cancer Targeted Therapy Market
CAGR	5%
Segment by Type	Tyrosine Kinase Inhibitors mTOR Inhibitors EGFR Inhibitors Anti-VEGF Monoclonal Antibody
Segment by Application	Renal Cell Cancer Renal Pelvis Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck, Novartis, Pfizer, Roche, Amgen, Aveo Pharmaceuticals, Exelixis, Bayer, Eisai, Wyeth
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Kidney Cancer Targeted Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Kidney Cancer Targeted Therapy Market report?

Ans: The main players in the Kidney Cancer Targeted Therapy Market are Merck, Novartis, Pfizer, Roche, Amgen, Aveo Pharmaceuticals, Exelixis, Bayer, Eisai, Wyeth

What are the Application segmentation covered in the Kidney Cancer Targeted Therapy Market report?

Ans: The Applications covered in the Kidney Cancer Targeted Therapy Market report are Renal Cell Cancer, Renal Pelvis Cancer, Others

What are the Type segmentation covered in the Kidney Cancer Targeted Therapy Market report?

Ans: The Types covered in the Kidney Cancer Targeted Therapy Market report are Tyrosine Kinase Inhibitors, mTOR Inhibitors, EGFR Inhibitors, Anti-VEGF Monoclonal Antibody

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Kidney Cancer Targeted Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Tyrosine Kinase Inhibitors

1.2.3 mTOR Inhibitors

1.2.4 EGFR Inhibitors

1.2.5 Anti-VEGF Monoclonal Antibody

1.3 Market by Application

1.3.1 Global Kidney Cancer Targeted Therapy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Renal Cell Cancer

1.3.3 Renal Pelvis Cancer

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Kidney Cancer Targeted Therapy Market Perspective (2020-2031)

2.2 Global Kidney Cancer Targeted Therapy Growth Trends by Region

2.2.1 Global Kidney Cancer Targeted Therapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Kidney Cancer Targeted Therapy Historic Market Size by Region (2020-2025)

2.2.3 Kidney Cancer Targeted Therapy Forecasted Market Size by Region (2026-2031)

2.3 Kidney Cancer Targeted Therapy Market Dynamics

2.3.1 Kidney Cancer Targeted Therapy Industry Trends

2.3.2 Kidney Cancer Targeted Therapy Market Drivers

2.3.3 Kidney Cancer Targeted Therapy Market Challenges

2.3.4 Kidney Cancer Targeted Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Kidney Cancer Targeted Therapy Players by Revenue

3.1.1 Global Top Kidney Cancer Targeted Therapy Players by Revenue (2020-2025)

3.1.2 Global Kidney Cancer Targeted Therapy Revenue Market Share by Players (2020-2025)

3.2 Global Kidney Cancer Targeted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Kidney Cancer Targeted Therapy Revenue

3.4 Global Kidney Cancer Targeted Therapy Market Concentration Ratio

3.4.1 Global Kidney Cancer Targeted Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Kidney Cancer Targeted Therapy Revenue in 2024

3.5 Global Key Players of Kidney Cancer Targeted Therapy Head office and Area Served

3.6 Global Key Players of Kidney Cancer Targeted Therapy, Product and Application

3.7 Global Key Players of Kidney Cancer Targeted Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Kidney Cancer Targeted Therapy Breakdown Data by Type

4.1 Global Kidney Cancer Targeted Therapy Historic Market Size by Type (2020-2025)

4.2 Global Kidney Cancer Targeted Therapy Forecasted Market Size by Type (2026-2031)

5 Kidney Cancer Targeted Therapy Breakdown Data by Application

5.1 Global Kidney Cancer Targeted Therapy Historic Market Size by Application (2020-2025)

5.2 Global Kidney Cancer Targeted Therapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Kidney Cancer Targeted Therapy Market Size (2020-2031)

6.2 North America Kidney Cancer Targeted Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Kidney Cancer Targeted Therapy Market Size by Country (2020-2025)

6.4 North America Kidney Cancer Targeted Therapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Kidney Cancer Targeted Therapy Market Size (2020-2031)

7.2 Europe Kidney Cancer Targeted Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Kidney Cancer Targeted Therapy Market Size by Country (2020-2025)

7.4 Europe Kidney Cancer Targeted Therapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Kidney Cancer Targeted Therapy Market Size (2020-2031)

8.2 Asia-Pacific Kidney Cancer Targeted Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Kidney Cancer Targeted Therapy Market Size by Region (2020-2025)

8.4 Asia-Pacific Kidney Cancer Targeted Therapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Kidney Cancer Targeted Therapy Market Size (2020-2031)

9.2 Latin America Kidney Cancer Targeted Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Kidney Cancer Targeted Therapy Market Size by Country (2020-2025)

9.4 Latin America Kidney Cancer Targeted Therapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Kidney Cancer Targeted Therapy Market Size (2020-2031)

10.2 Middle East & Africa Kidney Cancer Targeted Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Kidney Cancer Targeted Therapy Market Size by Country (2020-2025)

10.4 Middle East & Africa Kidney Cancer Targeted Therapy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Merck

11.1.1 Merck Company Details

11.1.2 Merck Business Overview

11.1.3 Merck Kidney Cancer Targeted Therapy Introduction

11.1.4 Merck Revenue in Kidney Cancer Targeted Therapy Business (2020-2025)

11.1.5 Merck Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Kidney Cancer Targeted Therapy Introduction

11.2.4 Novartis Revenue in Kidney Cancer Targeted Therapy Business (2020-2025)

11.2.5 Novartis Recent Development

11.3 Pfizer

11.3.1 Pfizer Company Details

11.3.2 Pfizer Business Overview

11.3.3 Pfizer Kidney Cancer Targeted Therapy Introduction

11.3.4 Pfizer Revenue in Kidney Cancer Targeted Therapy Business (2020-2025)

11.3.5 Pfizer Recent Development

11.4 Roche

11.4.1 Roche Company Details

11.4.2 Roche Business Overview

11.4.3 Roche Kidney Cancer Targeted Therapy Introduction

11.4.4 Roche Revenue in Kidney Cancer Targeted Therapy Business (2020-2025)

11.4.5 Roche Recent Development

11.5 Amgen

11.5.1 Amgen Company Details

11.5.2 Amgen Business Overview

11.5.3 Amgen Kidney Cancer Targeted Therapy Introduction

11.5.4 Amgen Revenue in Kidney Cancer Targeted Therapy Business (2020-2025)

11.5.5 Amgen Recent Development

11.6 Aveo Pharmaceuticals

11.6.1 Aveo Pharmaceuticals Company Details

11.6.2 Aveo Pharmaceuticals Business Overview

11.6.3 Aveo Pharmaceuticals Kidney Cancer Targeted Therapy Introduction

11.6.4 Aveo Pharmaceuticals Revenue in Kidney Cancer Targeted Therapy Business (2020-2025)

11.6.5 Aveo Pharmaceuticals Recent Development

11.7 Exelixis

11.7.1 Exelixis Company Details

11.7.2 Exelixis Business Overview

11.7.3 Exelixis Kidney Cancer Targeted Therapy Introduction

11.7.4 Exelixis Revenue in Kidney Cancer Targeted Therapy Business (2020-2025)

11.7.5 Exelixis Recent Development

11.8 Bayer

11.8.1 Bayer Company Details

11.8.2 Bayer Business Overview

11.8.3 Bayer Kidney Cancer Targeted Therapy Introduction

11.8.4 Bayer Revenue in Kidney Cancer Targeted Therapy Business (2020-2025)

11.8.5 Bayer Recent Development

11.9 Eisai

11.9.1 Eisai Company Details

11.9.2 Eisai Business Overview

11.9.3 Eisai Kidney Cancer Targeted Therapy Introduction

11.9.4 Eisai Revenue in Kidney Cancer Targeted Therapy Business (2020-2025)

11.9.5 Eisai Recent Development

11.10 Wyeth

11.10.1 Wyeth Company Details

11.10.2 Wyeth Business Overview

11.10.3 Wyeth Kidney Cancer Targeted Therapy Introduction

11.10.4 Wyeth Revenue in Kidney Cancer Targeted Therapy Business (2020-2025)

11.10.5 Wyeth Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Kidney Cancer Targeted Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Tyrosine Kinase Inhibitors

Table 3. Key Players of mTOR Inhibitors

Table 4. Key Players of EGFR Inhibitors

Table 5. Key Players of Anti-VEGF Monoclonal Antibody

Table 6. Global Kidney Cancer Targeted Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Kidney Cancer Targeted Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Kidney Cancer Targeted Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Kidney Cancer Targeted Therapy Market Share by Region (2020-2025)

Table 10. Global Kidney Cancer Targeted Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Kidney Cancer Targeted Therapy Market Share by Region (2026-2031)

Table 12. Kidney Cancer Targeted Therapy Market Trends

Table 13. Kidney Cancer Targeted Therapy Market Drivers

Table 14. Kidney Cancer Targeted Therapy Market Challenges

Table 15. Kidney Cancer Targeted Therapy Market Restraints

Table 16. Global Kidney Cancer Targeted Therapy Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Kidney Cancer Targeted Therapy Market Share by Players (2020-2025)

Table 18. Global Top Kidney Cancer Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer Targeted Therapy as of 2024)

Table 19. Ranking of Global Top Kidney Cancer Targeted Therapy Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Kidney Cancer Targeted Therapy Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Kidney Cancer Targeted Therapy, Headquarters and Area Served

Table 22. Global Key Players of Kidney Cancer Targeted Therapy, Product and Application

Table 23. Global Key Players of Kidney Cancer Targeted Therapy, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Kidney Cancer Targeted Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Kidney Cancer Targeted Therapy Revenue Market Share by Type (2020-2025)

Table 27. Global Kidney Cancer Targeted Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Kidney Cancer Targeted Therapy Revenue Market Share by Type (2026-2031)

Table 29. Global Kidney Cancer Targeted Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Kidney Cancer Targeted Therapy Revenue Market Share by Application (2020-2025)

Table 31. Global Kidney Cancer Targeted Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Kidney Cancer Targeted Therapy Revenue Market Share by Application (2026-2031)

Table 33. North America Kidney Cancer Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Kidney Cancer Targeted Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Kidney Cancer Targeted Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Kidney Cancer Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Kidney Cancer Targeted Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Kidney Cancer Targeted Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Kidney Cancer Targeted Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Kidney Cancer Targeted Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Kidney Cancer Targeted Therapy Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Kidney Cancer Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Kidney Cancer Targeted Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Kidney Cancer Targeted Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Kidney Cancer Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Kidney Cancer Targeted Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Kidney Cancer Targeted Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 48. Merck Company Details

Table 49. Merck Business Overview

Table 50. Merck Kidney Cancer Targeted Therapy Product

Table 51. Merck Revenue in Kidney Cancer Targeted Therapy Business (2020-2025) & (US$ Million)

Table 52. Merck Recent Development

Table 53. Novartis Company Details

Table 54. Novartis Business Overview

Table 55. Novartis Kidney Cancer Targeted Therapy Product

Table 56. Novartis Revenue in Kidney Cancer Targeted Therapy Business (2020-2025) & (US$ Million)

Table 57. Novartis Recent Development

Table 58. Pfizer Company Details

Table 59. Pfizer Business Overview

Table 60. Pfizer Kidney Cancer Targeted Therapy Product

Table 61. Pfizer Revenue in Kidney Cancer Targeted Therapy Business (2020-2025) & (US$ Million)

Table 62. Pfizer Recent Development

Table 63. Roche Company Details

Table 64. Roche Business Overview

Table 65. Roche Kidney Cancer Targeted Therapy Product

Table 66. Roche Revenue in Kidney Cancer Targeted Therapy Business (2020-2025) & (US$ Million)

Table 67. Roche Recent Development

Table 68. Amgen Company Details

Table 69. Amgen Business Overview

Table 70. Amgen Kidney Cancer Targeted Therapy Product

Table 71. Amgen Revenue in Kidney Cancer Targeted Therapy Business (2020-2025) & (US$ Million)

Table 72. Amgen Recent Development

Table 73. Aveo Pharmaceuticals Company Details

Table 74. Aveo Pharmaceuticals Business Overview

Table 75. Aveo Pharmaceuticals Kidney Cancer Targeted Therapy Product

Table 76. Aveo Pharmaceuticals Revenue in Kidney Cancer Targeted Therapy Business (2020-2025) & (US$ Million)

Table 77. Aveo Pharmaceuticals Recent Development

Table 78. Exelixis Company Details

Table 79. Exelixis Business Overview

Table 80. Exelixis Kidney Cancer Targeted Therapy Product

Table 81. Exelixis Revenue in Kidney Cancer Targeted Therapy Business (2020-2025) & (US$ Million)

Table 82. Exelixis Recent Development

Table 83. Bayer Company Details

Table 84. Bayer Business Overview

Table 85. Bayer Kidney Cancer Targeted Therapy Product

Table 86. Bayer Revenue in Kidney Cancer Targeted Therapy Business (2020-2025) & (US$ Million)

Table 87. Bayer Recent Development

Table 88. Eisai Company Details

Table 89. Eisai Business Overview

Table 90. Eisai Kidney Cancer Targeted Therapy Product

Table 91. Eisai Revenue in Kidney Cancer Targeted Therapy Business (2020-2025) & (US$ Million)

Table 92. Eisai Recent Development

Table 93. Wyeth Company Details

Table 94. Wyeth Business Overview

Table 95. Wyeth Kidney Cancer Targeted Therapy Product

Table 96. Wyeth Revenue in Kidney Cancer Targeted Therapy Business (2020-2025) & (US$ Million)

Table 97. Wyeth Recent Development

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Kidney Cancer Targeted Therapy Picture

Figure 2. Global Kidney Cancer Targeted Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Kidney Cancer Targeted Therapy Market Share by Type: 2024 VS 2031

Figure 4. Tyrosine Kinase Inhibitors Features

Figure 5. mTOR Inhibitors Features

Figure 6. EGFR Inhibitors Features

Figure 7. Anti-VEGF Monoclonal Antibody Features

Figure 8. Global Kidney Cancer Targeted Therapy Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Kidney Cancer Targeted Therapy Market Share by Application: 2024 VS 2031

Figure 10. Renal Cell Cancer Case Studies

Figure 11. Renal Pelvis Cancer Case Studies

Figure 12. Others Case Studies

Figure 13. Kidney Cancer Targeted Therapy Report Years Considered

Figure 14. Global Kidney Cancer Targeted Therapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Kidney Cancer Targeted Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Kidney Cancer Targeted Therapy Market Share by Region: 2024 VS 2031

Figure 17. Global Kidney Cancer Targeted Therapy Market Share by Players in 2024

Figure 18. Global Top Kidney Cancer Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer Targeted Therapy as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Kidney Cancer Targeted Therapy Revenue in 2024

Figure 20. North America Kidney Cancer Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Kidney Cancer Targeted Therapy Market Share by Country (2020-2031)

Figure 22. United States Kidney Cancer Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Kidney Cancer Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Kidney Cancer Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Kidney Cancer Targeted Therapy Market Share by Country (2020-2031)

Figure 26. Germany Kidney Cancer Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Kidney Cancer Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Kidney Cancer Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Kidney Cancer Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Kidney Cancer Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Kidney Cancer Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Kidney Cancer Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Kidney Cancer Targeted Therapy Market Share by Region (2020-2031)

Figure 34. China Kidney Cancer Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Kidney Cancer Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Kidney Cancer Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Kidney Cancer Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Kidney Cancer Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Kidney Cancer Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Kidney Cancer Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Kidney Cancer Targeted Therapy Market Share by Country (2020-2031)

Figure 42. Mexico Kidney Cancer Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Kidney Cancer Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Kidney Cancer Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Kidney Cancer Targeted Therapy Market Share by Country (2020-2031)

Figure 46. Turkey Kidney Cancer Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Kidney Cancer Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Kidney Cancer Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Merck Revenue Growth Rate in Kidney Cancer Targeted Therapy Business (2020-2025)

Figure 50. Novartis Revenue Growth Rate in Kidney Cancer Targeted Therapy Business (2020-2025)

Figure 51. Pfizer Revenue Growth Rate in Kidney Cancer Targeted Therapy Business (2020-2025)

Figure 52. Roche Revenue Growth Rate in Kidney Cancer Targeted Therapy Business (2020-2025)

Figure 53. Amgen Revenue Growth Rate in Kidney Cancer Targeted Therapy Business (2020-2025)

Figure 54. Aveo Pharmaceuticals Revenue Growth Rate in Kidney Cancer Targeted Therapy Business (2020-2025)

Figure 55. Exelixis Revenue Growth Rate in Kidney Cancer Targeted Therapy Business (2020-2025)

Figure 56. Bayer Revenue Growth Rate in Kidney Cancer Targeted Therapy Business (2020-2025)

Figure 57. Eisai Revenue Growth Rate in Kidney Cancer Targeted Therapy Business (2020-2025)

Figure 58. Wyeth Revenue Growth Rate in Kidney Cancer Targeted Therapy Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Kidney Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-38R2107

Fri Mar 14 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Radiotherapy Positioning Products Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34T16080

Fri Mar 14 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Radiation Oncology Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35A12535

Thu Mar 13 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Kidney Cancer Targeted Therapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-24A14985

Thu Mar 13 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions